DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ilaris (Canakinumab) - Current Clinical Trials

 
 



Ilaris Related Clinical Trials

Ilaris (Canakinumab) in the Schnitzler Syndrome [Completed]

Canakinumab for Treatment of Adult Onset Still's Disease [Recruiting]

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients [Completed]

A Pilot Study on the Effects of ILARIS« on Patients With Proliferative Diabetic Retinopathy (PDRP) [Recruiting]

Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA [Not yet recruiting]

Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy [Completed]

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies [Completed]

Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients [Completed]

├č-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab [Not yet recruiting]

Canakinumab in Patients With Active Hyper-IgD Syndrome [Completed]

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout [Completed]

Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients [Completed]

Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever [Completed]

Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF) [Completed]

To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the Knee [Completed]

Canakinumab for Pyoderma Gangrenosum [Recruiting]

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients [Terminated]

Efficacy Study of Canakinumab to Treat Urticaria [Recruiting]

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients [Recruiting]

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada [Completed]

a Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis Who Participated in the Study CACZ885G2301E1 [Recruiting]

An Open-label Extension Study With Canakinumab on the Treatment and Prevention of Gout Flares up to 3 Years [Completed]

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective [Recruiting]

The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients [Completed]

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease [Terminated]

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers [Recruiting]

Long Term Study of Canakinumab (ACZ885) in Patients With Gout [Completed]

Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF [Recruiting]

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease [Recruiting]

Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients [Completed]

Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP) [Active, not recruiting]

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes [Completed]

Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis [Completed]

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease [Completed]

Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis [Completed]

Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease [Withdrawn]

Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis [Completed]

A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica [Terminated]

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients [Completed]

Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017